697 related articles for article (PubMed ID: 28830976)
41. Omega-3 polyunsaturated fatty acid biomarkers and risk of type 2 diabetes, cardiovascular disease, cancer, and mortality.
Jiang H; Wang L; Wang D; Yan N; Li C; Wu M; Wang F; Mi B; Chen F; Jia W; Liu X; Lv J; Liu Y; Lin J; Ma L
Clin Nutr; 2022 Aug; 41(8):1798-1807. PubMed ID: 35830775
[TBL] [Abstract][Full Text] [Related]
42. Serum n-3 and n-6 polyunsaturated fatty acid profile as an independent predictor of cardiovascular events in hemodialysis patients.
Shoji T; Kakiya R; Hayashi T; Tsujimoto Y; Sonoda M; Shima H; Mori K; Fukumoto S; Tahara H; Shioi A; Tabata T; Emoto M; Nishizawa Y; Inaba M
Am J Kidney Dis; 2013 Sep; 62(3):568-76. PubMed ID: 23602192
[TBL] [Abstract][Full Text] [Related]
43. Low serum n-3 polyunsaturated fatty acid/n-6 polyunsaturated fatty acid ratio predicts neurological deterioration in Japanese patients with acute ischemic stroke.
Suda S; Katsumata T; Okubo S; Kanamaru T; Suzuki K; Watanabe Y; Katsura K; Katayama Y
Cerebrovasc Dis; 2013; 36(5-6):388-93. PubMed ID: 24248098
[TBL] [Abstract][Full Text] [Related]
44. Decreasing incidence of lacunar vs other types of cerebral infarction in a Japanese population.
Kubo M; Kiyohara Y; Ninomiya T; Tanizaki Y; Yonemoto K; Doi Y; Hata J; Oishi Y; Shikata K; Iida M
Neurology; 2006 May; 66(10):1539-44. PubMed ID: 16717214
[TBL] [Abstract][Full Text] [Related]
45. A prospective study of serum metabolites and risk of ischemic stroke.
Sun D; Tiedt S; Yu B; Jian X; Gottesman RF; Mosley TH; Boerwinkle E; Dichgans M; Fornage M
Neurology; 2019 Apr; 92(16):e1890-e1898. PubMed ID: 30867269
[TBL] [Abstract][Full Text] [Related]
46. The beneficial effect of statins treatment by stroke subtype.
Martínez-Sánchez P; Rivera-Ordóñez C; Fuentes B; Ortega-Casarrubios MA; Idrovo L; Díez-Tejedor E
Eur J Neurol; 2009 Jan; 16(1):127-33. PubMed ID: 19049507
[TBL] [Abstract][Full Text] [Related]
47. Impact of Intracranial Atherosclerotic Stenosis on the Prognosis in Acute Ischemic Stroke Patients with Cardioembolic Source.
Lee SJ; Lee DG; Lim DS; Hong S
Eur Neurol; 2015; 73(5-6):271-7. PubMed ID: 25895591
[TBL] [Abstract][Full Text] [Related]
48. [Epidemiology of the subtypes of stroke in hospitalised patients attended by neurologists: results of the EPICES registry (I)].
Arias-Rivas S; Vivancos-Mora J; Castillo J;
Rev Neurol; 2012 Apr; 54(7):385-93. PubMed ID: 22451124
[TBL] [Abstract][Full Text] [Related]
49. Association Between Omega-3 Fatty Acid Levels and Risk for Incident Major Bleeding Events and Atrial Fibrillation: MESA.
Kapoor K; Alfaddagh A; Al Rifai M; Bhatt DL; Budoff MJ; Nasir K; Miller M; Welty FK; McEvoy JW; Dardari Z; Shapiro MD; Blumenthal RS; Tsai MY; Blaha MJ
J Am Heart Assoc; 2021 Jun; 10(11):e021431. PubMed ID: 34041918
[TBL] [Abstract][Full Text] [Related]
50. Atrial fibrillation and stroke: clinical presentation of cardioembolic versus atherothrombotic infarction.
Arboix A; García-Eroles L; Massons JB; Oliveres M; Pujades R; Targa C
Int J Cardiol; 2000 Mar; 73(1):33-42. PubMed ID: 10748308
[TBL] [Abstract][Full Text] [Related]
51. Plasma lipid profile and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study.
Shahar E; Chambless LE; Rosamond WD; Boland LL; Ballantyne CM; McGovern PG; Sharrett AR;
Stroke; 2003 Mar; 34(3):623-31. PubMed ID: 12624282
[TBL] [Abstract][Full Text] [Related]
52. Ischemic stroke incidence in Santa Coloma de Gramenet (ISISCOG), Spain. A community-based study.
Alzamora MT; Sorribes M; Heras A; Vila N; Vicheto M; Forés R; Sánchez-Ojanguren J; Sancho A; ; Pera G
BMC Neurol; 2008 Mar; 8():5. PubMed ID: 18371212
[TBL] [Abstract][Full Text] [Related]
53. Plasma Retinol-Binding Protein 4 Levels and the Risk of Ischemic Stroke among Women.
Rist PM; Jiménez MC; Tworoger SS; Hu FB; Manson JE; Sun Q; Rexrode KM
J Stroke Cerebrovasc Dis; 2018 Jan; 27(1):68-75. PubMed ID: 28888344
[TBL] [Abstract][Full Text] [Related]
54. Plasma fibrinogen concentrations and risk of stroke and its subtypes among Japanese men and women.
Sato S; Iso H; Noda H; Kitamura A; Imano H; Kiyama M; Ohira T; Okada T; Yao M; Tanigawa T; Yamagishi K; Nakamura M; Naito Y; Shimamoto T
Stroke; 2006 Oct; 37(10):2488-92. PubMed ID: 16946147
[TBL] [Abstract][Full Text] [Related]
55. Hepatocyte Growth Factor Is Positively Associated With Risk of Stroke: The MESA (Multi-Ethnic Study of Atherosclerosis).
Bell EJ; Larson NB; Decker PA; Pankow JS; Tsai MY; Hanson NQ; Wassel CL; Longstreth WT; Bielinski SJ
Stroke; 2016 Nov; 47(11):2689-2694. PubMed ID: 27729582
[TBL] [Abstract][Full Text] [Related]
56. Procalcitonin and Midregional Proatrial Natriuretic Peptide as Markers of Ischemic Stroke: The Northern Manhattan Study.
Katan M; Moon YP; Paik MC; Mueller B; Huber A; Sacco RL; Elkind MS
Stroke; 2016 Jul; 47(7):1714-9. PubMed ID: 27197849
[TBL] [Abstract][Full Text] [Related]
57. N-terminal probrain natriuretic peptide as a biomarker of cardioembolic stroke.
Fonseca AC; Matias JS; Pinho e Melo T; Falcão F; Canhão P; Ferro JM
Int J Stroke; 2011 Oct; 6(5):398-403. PubMed ID: 21645267
[TBL] [Abstract][Full Text] [Related]
58. Greater Risk of Stroke of Undetermined Etiology in a Contemporary HIV-Infected Cohort Compared with Uninfected Individuals.
Chow FC; Price RW; Hsue PY; Kim AS
J Stroke Cerebrovasc Dis; 2017 May; 26(5):1154-1160. PubMed ID: 28262563
[TBL] [Abstract][Full Text] [Related]
59. Omega-3 fatty acids and mortality in patients referred for coronary angiography. The Ludwigshafen Risk and Cardiovascular Health Study.
Kleber ME; Delgado GE; Lorkowski S; März W; von Schacky C
Atherosclerosis; 2016 Sep; 252():175-181. PubMed ID: 27397734
[TBL] [Abstract][Full Text] [Related]
60. Secular trends in ischemic stroke subtypes and stroke risk factors.
Bogiatzi C; Hackam DG; McLeod AI; Spence JD
Stroke; 2014 Nov; 45(11):3208-13. PubMed ID: 25213343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
